Phase 1 Weight Loss Clinical Trials

4 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–4 of 4 trials

Recruiting

Phase 1

A Study to Evaluate the Pharmacokinetics of HRS9531 Injection in Participants With Mild, Moderate, and Normal Hepatic Function

Diabetes MellitusWeight Loss

Fujian Shengdi Pharmaceutical Co., Ltd.24 enrolled1 locationNCT07540754

Recruiting

Phase 1

Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS)

Weight LossAlcohol Use DisorderBariatric Surgery Patients

Yale University10 enrolled1 locationNCT07223983

Recruiting

Phase 1

Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents

ObesityBariatric SurgeryAdolescent Obesity+3 more

University of Colorado, Denver40 enrolled1 locationNCT06575738

Not Yet Recruiting

Phase 1

An Observer-Blinded Study to Determine the Feasibility of Pressure-Based Swedish Adjustable Gastric Band (SAGB) Adjustments in aiding weight loss

Bariatric Banding Weight Loss

Ethicon Endo-Surgery592 enrolledACTRN12607000340437